Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2017, Article ID 3179670, 5 pages
https://doi.org/10.1155/2017/3179670
Research Article

Assessment of Serum Vascular Endothelial Growth Factor Levels in Pregnancy-Induced Hypertension Patients

1Department of Biochemistry, Pt. J.N.M. Medical College and Dr. B.R.A.M. Hospital, Raipur, Chhattisgarh, India
2Department of Obstetrics and Gynaecology, Pt. J.N.M. Medical College and Dr. B.R.A.M. Hospital, Raipur, Chhattisgarh, India

Correspondence should be addressed to Pradeep Kumar Patra; ni.oc.oohay@4691pkp

Received 26 August 2016; Revised 29 November 2016; Accepted 13 December 2016; Published 4 January 2017

Academic Editor: Albert Fortuny

Copyright © 2017 Vibha Tandon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. G. Cunningham, P. C. MacDonald, and N. F. Gant, Williams' Obstetrics, Appleton & Lange, Norwalk, Conn, USA, 18th edition, 1989.
  2. B. M. Sibai, M. K. Ramadan, I. Usta, M. Salama, B. M. Mercer, and S. A. Friedman, “Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome),” American Journal of Obstetrics and Gynecology, vol. 169, no. 4, pp. 1000–1006, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. Department of Health, Why Women Die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994–1996, HMSO, London, UK, 1999.
  4. J. R. Barton and B. M. Sibai, “Prediction and prevention of recurrent preeclampsia,” Obstetrics and Gynecology, vol. 112, no. 2, pp. 359–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. A. Magee, M. Helewa, J. M. Moutquin, and P. Von Dadelszen, “Hypertension Guideline Committee, Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy,” Journal of Obstetrics and Gynaecology, vol. 30, no. 3, pp. S1–S48, 2008. View at Google Scholar
  6. N. Ferrara and W. J. Henzel, “Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 161, no. 2, pp. 851–858, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Senger, S. J. Galli, A. M. Dvorak, C. A. Perruzzi, V. S. Harvey, and H. F. Dvorak, “Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid,” Science, vol. 219, no. 4587, pp. 983–985, 1983. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Fava, N. J. Olsen, G. Spencer-Green et al., “Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue,” The Journal of Experimental Medicine, vol. 180, no. 1, pp. 341–346, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. L. F. Brown, K.-T. Yeo, B. Berse et al., “Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing,” The Journal of Experimental Medicine, vol. 176, no. 5, pp. 1375–1379, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. L. F. Brown, B. Berse, K. Tognazzi et al., “Vascular permeability factor mRNA and protein expression in human kidney,” Kidney International, vol. 42, no. 6, pp. 1457–1461, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. W. T. Monacci, M. J. Merrill, and E. H. Oldfield, “Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues,” American Journal of Physiology—Cell Physiology, vol. 264, no. 4, pp. C995–C1002, 1993. View at Google Scholar · View at Scopus
  12. N. Ferrara, J. Winer, and T. Burton, “Aortic smooth muscle cells express and secrete vascular endothelial growth factor,” Growth Factors, vol. 5, no. 2, pp. 141–148, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Breier, U. Albrecht, S. Sterrer, and W. Risau, “Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation,” Development, vol. 114, no. 2, pp. 521–532, 1992. View at Google Scholar · View at Scopus
  14. P. H. Andraweera, G. A. Dekker, J. A. Laurence, and C. T. Roberts, “Placental expression of VEGF family mRNA in adverse pregnancy outcomes,” Placenta, vol. 33, no. 6, pp. 467–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. E. Clark, S. K. Smith, A. M. Sharkey, and D. S. Charnock-Jones, “Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy,” Human Reproduction, vol. 11, no. 5, pp. 1090–1098, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Demir, U. A. Kayisli, Y. Seval et al., “Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis,” Placenta, vol. 25, no. 6, pp. 560–572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Demir, “Expression of VEGF receptors VEFGR-1 and VEGFR-2, angiopoietin receptors Tie-1 and Tie-2 in chorionic villi tree during early pregnancy,” Folia Histochemica et Cytobiologica, vol. 47, no. 3, pp. 435–445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. N. Baker, J. Krasnow, J. M. Roberts, and K.-T. Yeo, “Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia,” Obstetrics & Gynecology, vol. 86, no. 5, pp. 815–821, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Sharkey, J. C. Cooper, J. R. Balmforth et al., “Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia,” European Journal of Clinical Investigation, vol. 26, no. 12, pp. 1182–1185, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Kupferminc, Y. Daniel, T. Englender et al., “Vascular endothelial growth factor is increased in patients with preeclampsia,” American Journal of Reproductive Immunology, vol. 38, no. 4, pp. 302–306, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Lyall, I. A. Greer, F. Boswell, and R. Fleming, “Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia,” British Journal of Obstetrics and Gynaecology, vol. 104, no. 2, pp. 223–228, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. R. L. Kendall and K. A. Thomas, “Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 22, pp. 10705–10709, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Genbachev, R. Joslin, C. H. Dansky, B. M. Polliom, and S. J. Fischer, “Hypoxia alters early human cytotrophoblasts differentiation/invasion in-vitro and models the placental defects that occur in PE,” The Journal of Clinical Investigation, vol. 97, pp. 540–550, 1996. View at Publisher · View at Google Scholar
  24. B. L. Sheppard and J. Bonnar, “An ultra-structural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation,” British Journal of Obstetrics and Gynaecology, vol. 88, no. 7, pp. 695–705, 1981. View at Publisher · View at Google Scholar
  25. R. Pijnenborg, J. Anthony, D. A. Davey et al., “Placental bed spiral arteries in the hypertensive disorders of pregnancy,” British Journal of Obstetrics and Gynaecology, vol. 98, no. 7, pp. 648–655, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Rodgers, R. N. Taylor, and J. M. Roberts, “Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells,” American Journal of Obstetrics & Gynecology, vol. 159, no. 4, pp. 908–914, 1988. View at Publisher · View at Google Scholar · View at Scopus
  27. R. K. Bhatia, S. F. Bottoms, A. A. Saleh, G. S. Norman, E. F. Mammen, and R. J. Sokol, “Mechanisms for reduced colloid osmotic pressure in preeclampsia,” American Journal of Obstetrics & Gynecology, vol. 157, no. 1, pp. 106–108, 1987. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Roberts, M. D. Lindheimer, and J. M. Davison, “Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy,” American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 270, no. 2, pp. F338–F343, 1996. View at Google Scholar · View at Scopus
  29. D.-H. Kang, J. Finch, T. Nakagawa et al., “Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link,” Journal of Hypertension, vol. 22, no. 2, pp. 229–235, 2004. View at Publisher · View at Google Scholar · View at Scopus